Related Experiment Video

Updated: Jul 9, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

Mild cognitive impairment

N T Aggarwal1

  • 1Rush Alzheimer's Disease Center, Department of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612, USA. neelum_t_aggarwal@rsh.net

Panminerva Medica
|December 20, 2007
PubMed

Insights

Mild cognitive impairment (MCI) is common in older adults and may increase the risk of dementia. Research is ongoing to find effective prevention and treatment strategies for MCI.

Area of Science:

  • Gerontology
  • Neurology
  • Cognitive Science

Background:

  • Cognitive abilities in older adults vary widely, from normal function to dementia.
  • Mild cognitive impairment (MCI) describes cognitive decline that doesn't meet dementia criteria.
  • MCI is prevalent in the elderly and linked to higher risks of Alzheimer's disease, parkinsonism, and disability.

Purpose of the Study:

  • To review the current understanding of mild cognitive impairment (MCI).
  • To discuss diagnostic approaches and prognostic indicators for MCI.
  • To examine therapeutic and preventive strategies for MCI.

Main Methods:

  • Review of existing literature on mild cognitive impairment.
  • Analysis of clinical assessment methods for cognitive function.
  • Evaluation of structural MRI's role in MCI diagnosis and prognosis.
  • Assessment of therapeutic trial outcomes and ongoing prevention studies for MCI.

Main Results:

  • Mild cognitive impairment (MCI) is common in older adults.
  • MCI is associated with increased risk for Alzheimer's disease, parkinsonian signs, and disability.
  • Current treatments targeting cholinesterase inhibitors show limited short-term benefits in MCI.

Conclusions:

  • Clinical assessment of cognitive function and structural MRI are crucial for MCI diagnosis and prognosis.
  • Pharmacologic prevention studies for MCI are underway and hold promise.
  • Further research is needed to develop effective interventions for MCI.

More Related Videos

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients07:42

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Intellectual Disability01:29

Intellectual Disability

Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.